These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 18047741)

  • 1. Role of the ubiquitin proteasome system in renal cell carcinoma.
    Corn PG
    BMC Biochem; 2007 Nov; 8 Suppl 1(Suppl 1):S4. PubMed ID: 18047741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the ubiquitin proteasome system in Alzheimer's disease.
    Upadhya SC; Hegde AN
    BMC Biochem; 2007 Nov; 8 Suppl 1(Suppl 1):S12. PubMed ID: 18047736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patented small molecule inhibitors in the ubiquitin proteasome system.
    Guédat P; Colland F
    BMC Biochem; 2007 Nov; 8 Suppl 1(Suppl 1):S14. PubMed ID: 18047738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles and potential therapeutic targets of the ubiquitin proteasome system in muscle wasting.
    Nury D; Doucet C; Coux O
    BMC Biochem; 2007 Nov; 8 Suppl 1(Suppl 1):S7. PubMed ID: 18047744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the ubiquitin proteasome system in Parkinson's disease.
    Lim KL; Tan JM
    BMC Biochem; 2007 Nov; 8 Suppl 1(Suppl 1):S13. PubMed ID: 18047737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.
    Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER
    Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the UPS in cystic fibrosis.
    Turnbull EL; Rosser MF; Cyr DM
    BMC Biochem; 2007 Nov; 8 Suppl 1(Suppl 1):S11. PubMed ID: 18047735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
    Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM
    J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
    Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel VHL target genes and relationship to hypoxic response pathways.
    Maina EN; Morris MR; Zatyka M; Raval RR; Banks RE; Richards FM; Johnson CM; Maher ER
    Oncogene; 2005 Jun; 24(28):4549-58. PubMed ID: 15824735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ubiquitin proteasome system in Huntington's disease and the spinocerebellar ataxias.
    Davies JE; Sarkar S; Rubinsztein DC
    BMC Biochem; 2007 Nov; 8 Suppl 1(Suppl 1):S2. PubMed ID: 18047739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the UPS as therapy in multiple myeloma.
    Chauhan D; Bianchi G; Anderson KC
    BMC Biochem; 2008 Oct; 9 Suppl 1(Suppl 1):S1. PubMed ID: 19007431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Roles of Cullin-2 E3 Ubiquitin Ligase Complex in Cancer.
    Liu X; Zurlo G; Zhang Q
    Adv Exp Med Biol; 2020; 1217():173-186. PubMed ID: 31898228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the VHL (von Hippel-Lindau) gene in renal cancer: a multifunctional tumour suppressor.
    Nyhan MJ; O'Sullivan GC; McKenna SL
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):472-8. PubMed ID: 18481984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The UPS: a promising target for breast cancer treatment.
    Sato K; Rajendra E; Ohta T
    BMC Biochem; 2008 Oct; 9 Suppl 1(Suppl 1):S2. PubMed ID: 19007432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wrenches in the works: drug discovery targeting the SCF ubiquitin ligase and APC/C complexes.
    Cardozo T; Pagano M
    BMC Biochem; 2007 Nov; 8 Suppl 1(Suppl 1):S9. PubMed ID: 18047746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of PI3K signalling pathway in clear cell renal cell carcinoma in relation to VHL and HIF status.
    Tumkur Sitaram R; Landström M; Roos G; Ljungberg B
    J Clin Pathol; 2021 Apr; 74(4):216-222. PubMed ID: 32467322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
    Liu MY; Poellinger L; Walker CL
    Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine kinase inhibitors in renal cell carcinoma.
    Potti A; George DJ
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6371S-6S. PubMed ID: 15448033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of receptor for activated C kinase 1 protein by the von Hippel-Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasiveness.
    He X; Wang J; Messing EM; Wu G
    Oncogene; 2011 Feb; 30(5):535-47. PubMed ID: 20871634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.